Celltrion Pharm

068760.KQ

28.25 USD

-0.05

-0.18%

Overview

Last close

28.25 usd

Market cap

1.25B usd

52 week high

52.45 usd

52 week low

25.63 usd

Target price

98.15 usd

Valuation

P/E

N/A

Forward P/E

49.505

Price/Sales

6.2989

Price/Book Value

3.8524

Enterprise Value

1.28B usd

EV/Revenue

3.0568

EV/EBITDA

20.6463

Key financials

Revenue TTM

198.27M usd

Gross Profit TTM

58.34M usd

EBITDA TTM

30.89M usd

Earnings per Share

N/A usd

Dividend

0.14 usd

Total assets

503.50M usd

Net debt

58.35M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.